Treating the AD Patient During COVID-19

JDD Podcast: Ask the Investigator
06/11/2020 31 min
Treating the AD Patient During COVID-19

Listen "Treating the AD Patient During COVID-19"

Descargar episodio Ver en sitio original

Episode Synopsis

Atopic dermatitis is a relentless, recurring, unreasonable, often recalcitrant inflammatory skin disease that impacts millions of children and adults in the United States alone and requires a tailored treatment plan...
The post Treating the AD Patient During COVID-19 appeared first on JDDonline - Journal of Drugs in Dermatology.

More episodes of the podcast JDD Podcast: Ask the Investigator

From Crushing Childhood Challenges to Champion of Corticosteroid Stewardship: An Eczema Patient’s Perspective 05/12/2025
Field (Cancerization) Tested: Patient and Provider Perspectives on Klisyri 21/11/2025
Steer-oid Stewardship: Reining In and Reinforcing the Guardrails on Dermatology’s Workhorse 06/11/2025
Filter Needed: Emerging Science in and Approaches to Sunscreen Safety 17/10/2025
Ceut up: Incorporating a New OTC Concept into the Acne Armamentarium 03/10/2025
Podcasting on Podcasts: Dr. Adam Friedman and Dr. Jim Del Rosso Unpack the Mics 05/09/2025
Asking about Acne: A Palpable and Poignant Patient Perspective 15/08/2025
Thin Skinned: Topical Steroid Safety and Legal Landmines 02/05/2025
From Rags to Itches: The Evolution of Topical and Systemic Options for Pruritus 04/04/2025
Touching on Tailored Topical for Tons of Tough Treatment Tchallenges 28/03/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA